BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33865430)

  • 1. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
    Eijkelboom AH; de Munck L; Vrancken Peeters MTFD; Broeders MJM; Strobbe LJA; Bos MEMM; Schmidt MK; Guerrero Paez C; Smidt ML; Bessems M; Verloop J; Linn S; Lobbes MBI; Honkoop AH; van den Bongard DHJG; Westenend PJ; Wesseling J; Menke-van der Houven van Oordt CW; Tjan-Heijnen VCG; Siesling S;
    J Hematol Oncol; 2021 Apr; 14(1):64. PubMed ID: 33865430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
    Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
    Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
    Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
    Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.
    Minami CA; Kantor O; Weiss A; Nakhlis F; King TA; Mittendorf EA
    J Am Coll Surg; 2020 Oct; 231(4):434-447.e2. PubMed ID: 32771654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
    Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995.
    Richardson LC; Schulman J; Sever LE; Lee NC; Coate RJ
    Breast Cancer Res Treat; 2001 Sep; 69(2):133-42. PubMed ID: 11759819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women.
    Buscariollo DL; Cronin AM; Borstelmann NA; Punglia RS
    Breast Cancer Res Treat; 2019 Feb; 173(3):709-717. PubMed ID: 30406869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.
    de Glas NA; de Craen AJ; Bastiaannet E; Op 't Land EG; Kiderlen M; van de Water W; Siesling S; Portielje JE; Schuttevaer HM; de Bock GT; van de Velde CJ; Liefers GJ
    BMJ; 2014 Sep; 349():g5410. PubMed ID: 25224469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; Van Dijck JA; Wobbes T
    Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.